A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC752 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}CG6420d03901 to be Release 3 genomic coordinate 22540396 on chromosome arm 3R. This corresponds to 97C5 on the Release 3 and Release 5 genome maps. The predicted position of PBac{WH}CG31323f04673 on the Release 5 map is 97A2. Consequently, the cytological breakpoints of Df(3R)BSC752 are predicted to be 97A2;97C5.